Management of bleeding associated with dabigatran and rivaroxaban: A survey of current practices

Thrombosis Research

Volumn 132, Issue 2, 2013, Pages

  Baumann Kreuziger, Lisa M ^a   Reding, Mark T ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; DABIGATRAN; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RIVAROXABAN;

BLEEDING; HEALTH SURVEY; HUMAN; LETTER; MEDICAL PRACTICE; PRIORITY JOURNAL; PROTHROMBIN TIME; THROMBIN TIME;

ANTICOAGULANTS; ANTITHROMBINS; BENZIMIDAZOLES; BETA-ALANINE; DATA COLLECTION; FEMALE; HEMORRHAGE; HUMANS; MALE; MORPHOLINES; PHYSICIAN'S PRACTICE PATTERNS; THIOPHENES;

EID: 84883749228     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2013.07.011     Document Type: Letter

References (15)

1. J. van Ryn, J. Stangier, S. Haertter, K.H. Liesenfeld, W. Wienen, and M. Feuring Dabigatran etexilate-a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity Thromb Haemost 103 2010 1116 1127
2. S. Schulman, and M. Crowther How I treat with anticoagulants in 2012: new and old anticoagulants, and when and how to switch Blood 119 2012 3016 3023
3. S. Kaatz, P. Kouides, D. Garcia, A.C. Spyropolous, M. Crowther, and J.D. Douketis Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors Am J Hematol 87 Suppl. 1 2012 S141 S145
4. M.M. Samama Which test to use to measure the anticoagulant effect of rivaroxaban: The anti-factor Xa assay J Thromb Haemost 11 2013 579 580
5. A. Tripodi Which test to use to measure the anticoagulant effect of rivaroxaban: The prothrombin time test J Thromb Haemost 11 2013 576 578
6. L. Baumann Kreuziger, C. Morton, and D. Dries New anticoagulants: A concise review J Trauma Acute Care Surg 73 2012 983 992
7. S. Schulman, and C. Kearon Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients J Thromb Haemost 3 2005 692 694
8. D. Braithwaite, J. Emery, S. De Lusignan, and S. Sutton Using the Internet to conduct surveys of health professionals: a valid alternative? Fam Pract 20 2003 545 551
9. A. Viera, and T. Edwards Does an offer for a free on-line continuing medical education (CME) activity increase physician survey response rate? A randomized trial BMC Res Notes 5 2012 129
10. Grifols Biologicals Inc. Profilnine® SD prescribing information August 2010
11. Baxter FEIBA® prescribing information October 2010 [3/11/2013]
12. Novo Nordisk Inc. NovoSeven RT® Coagulation Factor VIIa prescribing information January 2010 [3/11/2013]
13. B.I. Eriksson, D.J. Quinlan, and J.I. Weitz Comparative pharmacodynamics and pharmacokinetics of oral direct thrombin and factor xa inhibitors in development Clin Pharmacokinet 48 2009 1 22
14. J. Stangier, and M. Feuring Using the HEMOCLOT direct thrombin inhibitor assay to determine plasma concentrations of dabigatran Blood Coagul Fibrinolysis 23 2012 138 143
15. E. Lindhoff-Last, M.M. Samama, T.L. Ortel, J.I. Weitz, and T.E. Spiro Assays for measuring rivaroxaban: their suitability and limitations Ther Drug Monit 32 2010 673 679